Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Viewray, Incorporated — Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
182 daysmedian FDA review time
327 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K212958 | MRIdian Linac System | Viewray, Incorporated | 2021-12-14 | 89 | 0 |
| K181989 | MRIdian Linac System | Viewray, Incorporated | 2019-02-20 | 209 | 0 |
| K170751 | MRIdian Linac System with 138-leaf Collimator | Viewray, Incorporated | 2017-06-07 | 86 | 1 |
| K162393 | The ViewRay (MRIdian) Linac System | Viewray, Incorporated | 2017-02-24 | 182 | 0 |
| K111862 | VIEWRAY SYSTEM | Viewray, Incorporated | 2012-05-22 | 327 | 7 |
| K102915 | VIEWRAY TREATMENT PLANNING AND DELIVERY SYSTEM | Viewray, Incorporated | 2011-01-12 | 103 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda